X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TRANSCHEM Share Price   (TRCH)

Here is the latest stock price and chart of TRANSCHEM. For a sector overview, read our pharmaceuticals sector report.

REFRESH
Live BSE Quotes May 30, 2017 02:46:00 PM
Price (Rs)27.35 Open (Rs) 27.35 High (Rs) 27.35 Low (Rs) 27.35
% Change-1.97 Volume 100 Value (Rs) 2,735 52-Week H/L 36.00 / 15.15
Live NSE Quotes
Not listed
  BSE Sensex | CNX Nifty

Charts
TRANSCHEM Share Price Chart (Rs) - 1 Year
Loading...
 
     
PERIOD
Advanced Charts new


Today's Market

Sensex Trades on a Volatile Note; Pharma Sector Leads Gains(01:30 pm)

After opening the day negative, Indian share markets witnessed volatile activity and are currently trading flat with a positive bias.

Related Views On News

Lupin: Decline in US Business Impacts Overall Growth (Quarterly Results Update - Detailed)

May 29, 2017

Currency fluctuation and one time provision impacts operating margins.

Glenmark Pharma: Lower Zetia Sales leads to Subdued Growth (Quarterly Results Update - Detailed)

May 18, 2017

Base price erosion in the US and lower Zetia sales impacts profits.

Sun Pharma: Slow Growth Across Major Markets (Quarterly Results Update - Detailed)

Mar 11, 2017

Sun Pharma has announced its December quarter (3QFY17) results. The company has reported 8% YoY growth in sales and a decline of 4.7% YoY in the net profits.

Cipla: Operating Margins Improve (Quarterly Results Update - Detailed)

Mar 8, 2017

Cipla has announced its results for the December quarter (1QFY17) results. The company has reported a decline of 6.4% YoY in sales while profits were down by 43.7% YoY.

Lupin: US Business Drives Growth (Quarterly Results Update - Detailed)

Mar 8, 2017

Lupin has announced its 3QFY17 results. Net sales have grown by 31.5% YoY and net profits have surged by 20.7% YoY. Here is our analysis of the results.

More Views on News

Most Popular

Of "Shaky" Demonetisation Statistics, Arun Jaitley and Black Money(Vivek Kaul's Diary)

May 22, 2017

When it comes to identifying black money, 2016-2017 has been a fairly average year for the income tax department, demonetisation notwithstanding.

Just Like Before, the Market is about to Crash(Outside View)

May 17, 2017

Markets are at record highs. Fear is at record lows. How does this end? When does this end?

Why We Skipped This 70% Gainer(The 5 Minute Wrapup)

May 18, 2017

Underreporting of bad loans by some private sector banks casts a cloud over the sector's clean image so far.

Double Your Money with Derivatives(Daily Profit Hunter)

May 19, 2017

Asad Dossani discusses how you can double your money with derivatives.

The Rise and Fall of Shilpi Cable Technologies(Chart Of The Day)

May 19, 2017

How Shilpi Cable lost over 70% of its market cap in one month.

More

TRACK TRANSCHEM

  • Track your investment in TRANSCHEM with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MARKET STATS